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Forskolin is a potent activator of the cyclic AMP-generating system in many tissues. In dog thyroid slices, 
the enhancement of cyclic AMP level was rapid, sustained in the presence of forskolin, but easily reversible 
after its withdrawal. Contrary to TSH, forskolin induced little apparent desensitization. Forskolin 
potentiated the effects of TSH, PGEl and cholera toxin. However, the forskolin-induced cyclic AMP 
accumulation was still sensitive to inhibitors of dog thyroid adenylate cyclase such as iodide, 
norepinephrine and adenosine. As fluoride, but contrary to TSH and PGEI, forskolin stimulated adenylate 
cyclase in a medium where Mg’+ was replaced by Mn2+. This suggests that in thyroid, as in other tissues, 
forskolin acts beyond the receptor level but, as it potentiates hormone action and does not impair 
modulation by inhibitors, it may interact with the nucleotide-binding regulatory proteins. Forskolin 
mimicked the effect of TSH on iodide organification and secretion. 
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1. INTRODUCTION 
Forskolin is an extremely powerful activator of 
the cyclic AMP-generating system in both intact 
cells and plasma membranes [ 11. These studies 
were designed to determine whether forskolin ac- 
tivates adenylate cyclase in dog thyroid and conse- 
quently reproduces the effect of TSH ascribed to 
intracellular cyclic AMP rise. 
the slices were incubated at 37’C in Krebs-Ringer 
bicarbonate buffer (pH 7.4), saturated with 95% 
02-5070 CO2 and enriched with 8 mM glucose and 
0.5 mg bovine serum albumin/ml. The slices were 
always preincubated 60 min before the test incuba- 
tion in fresh medium. 
2.2. Cyclic AMP assay 
2. MATERIALS AND METHODS 
At the end of the incubation, the slices were 
dropped in 1.5 ml of boiling deionized water for 
5 min. Cyclic AMP was measured as in [2,3]. 
2.1. Slices incubation 2.3. Iodine metabolism 
Thyroid slices were prepared with a Stadie Riggs 
microtome (Arthur Thomas, Philadelphia, PA) 
from thyroids of dog pretreated with thyroid ex- 
tract daily for l-3 days (lOOmg/lO kg, Thyranon, 
Organon, 0s~). Within 30min after resectioning, 
Abbreviations: TSH, thyroid stimulating hormone; 
PGEl, prostaglandin El; cyclic AMP, 3 ’ ,5 ’ -adenosine 
monophosphate 
To measure thyroid hormone secretion, dogs 
were injected with 150&i 1311 before the ad- 
ministration of thyroid extract and the incubation 
medium supplemented with NaC104 (1 mM) and 
methimazole (2mM). Secretion was estimated by 
the ratio between the butanol-extractable radioac- 
tivity in the medium at the end of the incubation, 
and the total radioactivity of the slices before the 
incubation (olo BEI) [4]. 
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For the measurement of iodide incorporation in- 
to iodoproteins, slices were incubated for 45 min in 
medium supplemented with KI (4OpM) and 1311 
(0.5,&i/ml), and homogenized in a methimazole 
solution (2mM). The proteins were precipitated 
with 5% trichloroacetic acid [5]. Results were ex- 
pressed as the ratio between trichloroacetic acid- 
precipitable radioactivity and the total radioactiv- 
ity in the slices. 
PGEi from Upjohn Company (Kalamazoo MI). 
The phosphodiesterase inhibitor R020-1724 was a 
gift from Hoffman-La Roche (Nutley NY). Radio- 
active materials were provided by the Radiochem- 
ical Centre (Amersham). All of the other reagents 
were of the highest purity commercially available. 
3. RESULTS AND DISCUSSION 
2.4. Membrane preparation 
The thyroids were sliced, chopped and 
homogenized at 4°C in a Dounce tissue grinder, 
containing 50mM Tris-HCl buffer with sucrose 
250mM, EDTA 1 mM and EGTA 1 mM. The 
homogenate was centrifuged 5 min at 500 x g and 
the pellet discarded. A 10000 x g pellet obtained 
after 20min centrifugation was washed once and 
then resuspended in a 50mM Tris-HCI (pH 7.4) 
buffer at 0.5-1.5mg protein/ml and assayed 
immediately. 
3.1. Characterization of forskolin action 
on cyclic AMP level in dog thyroid slices 
Forskolin rapidly and markedly enhanced cyclic 
AMP accumulation. The effect was already signifi- 
cant (50%) at 25nM. At 10pM the effect was 
marked (SOOcr/o) at 3 min and maximal at 30 min 
(1200%). The effect of forskolin is easily reversi- 
ble, contrary to TSH action (table 1). 
Table 1 
Effect of washing on forskolin or TSH-induced cyclic 
2.5. Adenylate cyclase assay AMP accumulation 
Adenylate cyclase assay was performed as in [6]. 
The membranes were incubated 10min at 30°C in 
the following medium: 50mM Tris-HCl buffer 
(pH 7.4); NaCl30 mM; phosphocreatine (disodium 
salt) 5 mM; creatine kinase lOU/ml; MgClz 5 mM; 
ATP 0.1 mM; EGTA 0.1 mM; GTP 0.1 mM; iso- 
butylmethylxanthine 0.8 mM; sucrose 250 mM; 
bovine serum albumin 0.04% and l-2 x lo6 cpm 
[w~‘P]ATP. Medium (50~1) was pre-warmed 
5min before the addition of 50~1 membrane 
preparation. Under the conditions used cyclic 
AMP generation was linear both with time up to 
20min and with up to 120rg protein/tube. 
Washing time (min) 
Forskolin was dissolved in ethanol and used with 
the appropriate controls. Protein concentration 
was estimated by the adapted method of Lowry [7] 
using bovine serum albumin as standard. Results 
are expressed as mean + SEM of triplicate sets of 
slices in one typical experiment. 
0 2 5 10 30 60 
A 100 79 59 36 
B 100 52 29 17 5.5 5.1 
After 1 h incubation in the presence of TSH (1 mu/ml) 
(A) or forskolin (1OpM) (B) and R020-1724 (0.1 mM) as 
phosphodiesterase inhibitor, the slices were dropped 
successively in 2 vials of lOOm1 fresh medium and then 
reincubated for 2-60min in fresh medium without any 
addition to follow cyclic AMP disappearance in the 
slices. The results are expressed as percent of the value 
obtained before the washing-basal value: 92 + 25 
pmol/lOOmg wet wt tissue; TSH stimulated tissue, 
1325 * 92; forskolin-stimulated tissue, 1891 -t 110 
2.6. Materials 
TSH as thytropar was obtained from Armour 
Pharmaceuticals (Phoenix AZ), forskolin from 
Hoechst Pharmaceuticals (Bombay), norepine- 
phrine from Calbiochem (Lucerne), cholera toxin 
(Dr R.A. Finkelstein preparation) from Schwarz- 
man (Becton Dickinson, Orangeburg NY) and 
Thyroid slices are sensitive to TSH desensitiza- 
tion. Indeed a second TSH challenge increased the 
cyclic AMP level to only 40-50% of the level 
reached in control slices stimulated for the first 
time [8,9]. Under the same conditions a second for- 
skolin challenge enhanced cyclic AMP levels 
almost to the same levels as in control slices 
@O-90%) (fig. 1). 
The characteristics of the forskolin effect on 
cyclic AMP accumulation in thyroid are thus 
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Fig. 1. TSH- or forskolin-induced desensitization. The 
experimental protocol involved 3 consecutive incuba- 
tions (I) 2 h * the stimulators and caffeine 10mM; (II) 
1 h in medium with no addition; (III) 21 min + stimu- 
lator and caffeine 10mM. A rinse in lOOm1 medium at 
37°C was performed between incubations I-II, and 
II-III: (A) stimulation in incubation III only = one 
challenge; (B) stimulation in incubation I only and cyclic 
AMP measured at the end of incubation III = residual 
cyclic AMP; (C) stimulation in incubation I and 
restimulation in incubation III = two challenges. Results 
are expressed as pmol cyclic AMP + SEM/lOOmg wet 
wt tissue. 
pmotos CAMP 
lOOmg wet weight 
4000: 
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similar to those reported for brain [lo]. Its action 
is rapid and steady for several hours. It is already 
active at lo-’ M and is easily washed off. There is 
little apparent desensitization. This will allow one 
to test the effects of pulses of increased cyclic AMP 
levels. 
The effects of TSH, PGEl and cholera toxin on 
cyclic AMP accumulation are greatly potentiated 
by forskolin (fig. 2). The response to TSH was in- 
creased by forskolin even at maximal concentra- 
tion of the hormone, but the tissue sensitivity to 
TSH was not increased (fig. 3). Forskolin-induced 
cyclic AMP accumulation was inhibited by iodide, 
norepinephrine and adenosine, known as adenylate 
cyclase inhibitors in dog thyroid (fig. 4) [ 1 l-131. 
The fact that forskolin potentiates the effects of 
stimulators such as TSH and PGEl on cyclic AMP 
pMolos CAMP 
100 mg wet weight 
5 000 
1 / A 
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2000. / t 
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Fig. 3. Effect of forskolin on the cyclic AMP response 
to increasing [TSH]. The test incubation in the presence 
of forskolin (75 nM), TSH, and R020-1724 (0.1 mM) as 
phosphodiesterase inhibitor lasted 30 min. 
Fig. 2. Effect of forskolin on known stimulators of 
cyclic AMP accumulation in dog thyroid. The test in- 
cubation in the presence of the agent and a phospho- 
diesterase inhibitor lasted 30min. Cholera toxin (ch. 
Toxin) was already present in the 60min preincubation: 
PGEI, 2.8pM; ch. toxin, lpg/ml; TSH, 1 mu/ml. 
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Fig. 4. Effect of known inhibitors of the TSH stimula- 
tion on forskolin stimulation of cyclic AMP accumula- 
tion in dog thyroid slices. The test incubation in the 
presence of R020-1724 (0.1 mM), forskolin (lOaM), 
TSH (1 mu/ml), and the inhibitors lasted 30 min. KI was 
already present in the 1 h preincubation: NE, norepine- 
phrine 10pM; Ad., adenosine 200rM; KI, potassium 
iodide 1OOpM. The basal value in the experiments 
presented are 73-120 pmol cyclic AMP/lOOmg wet wt 
tissue. 
accumulation and that the forskolin-enhanced 
cyclic AMP levels are still submitted to the dif- 
ferent negative controls operating at various levels 
of the cyclase system suggest that forskolin- 
activated cyclase is still coupled to its stimulatory 
and/or inhibitory regulatory proteins. 
3.2. Effects on adenylate cyclase activity 
Forskolin stimulates adenylate cyclase activity 
with app. K, from 1-10,uM. The activation was 
already observed at 2min, the shortest time 
studied, and was constant for up to 20min (not 
shown). These properties are compatible with the 
effect on cyclic AMP levels in intact cells. 
The replacement of Mg2+ by Mn2+ in the cyclase 
incubation medium uncouples receptor from 
cyclase in rat erythrocytes [14]. In this study we 
show a similar uncoupling of TSH and PGEr ac- 
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Fig. 5. Effect of Mn2+ on thyroid adenylate cyclase ac- 
tivation. Forskolin and PGEr were dissolved in ethanol 
(5% final cont.). The reaction was started with 35pg 
membrane protein added/tube: T, TSH lOmU/ml; F, 
fluoride 10mM; Eth., ethanol 5%; PGE1, prostaglandin 
El 56pM; FO, forskolin 1OpM; Mg2+ and Mn’+, 5 mM. 
tion on thyroid cyclase. The replacement of Mg2+ 
(5 mM) by Mn2+ (5 mM) in the incubation mixture 
enhanced the basal adenylate cyclase activity but 
blocked the TSH (lOmU/ml) and PGEr (28pM) 
response. On the contrary, the forskolin (10pM) 
and fluoride (10 mM) stimulations were preserved 
in the same experiment (fig. 5). Thus under such 
conditions, forskolin and fluoride, which acts on 
G/F, still stimulate the cyclase. This suggests that 
in thyroid, as in other tissues, this drug acts beyond 
the receptor level but, as it potentiates hormone ac- 
tion and does not impair the modulation by in- 
hibitors, it may interract with the nucleotide bin- 
ding regulatory proteins as proposed in platelets 
]151. 
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Table 2 
Effect of forskolin on iodine metabolism (see section 2) 
- Forskolin (1 PM) Parameter 
4.69 f 0.9 9.34 f 1 % PB i3rIa 
1.07 f 0.05 3.1 +0.16 % BE “rib 
a % PB 13’1 = evaluation of iodide organification; i.e., 
hormone synthesis 
b % BE “‘1 = evaluation of hormone secretion 
3.3. Effect on iodine metabolism 
TSH stimulates iodide organification and 
thyroid hormone secretion. It has been proposed 
that the reproduction of a hormonal effect by for- 
skolin could constitute a new criterion of the 
validity of Sutherland’s model in a given system 
[lo]. As shown in table 2 for iodide organification 
and secretion, forskolin mimicks the effects of 
TSH. These data therefore further confirm that 
these effects of TSH are mediated by cyclic AMP 
[161. 
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